Autres langues Evaxion A/S

Actions

EVAX

US29970R3030

Recherche biotechnologique et médicale

Marché Fermé - 22:00:00 06/10/2026 Varia. 5j. Varia. 1 janv.
3,160 USD +0,32% Graphique intraday de Evaxion A/S -2,47% -33,75%

Autres langues

06/10 European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
05/10 Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
02/10 Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
25/09 European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week
23/09 European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
22/09 European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading
18/09 European Equities Traded in the US as American Depositary Receipts Drop in Friday Trading
16/09 European Equities Traded in US as ADRs Rise in Wednesday Trading
14/09 Evaxion applies its AI-Immunology™ platform in autoimmune diseases
14/09 Evaxion Applies AI-Immunology Platform In Autoimmune Diseases
10/09 European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading
09/09 European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
08/09 European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
04/09 European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading
03/09 European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading
02/09 European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
31/08 European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading
21/08 Evaxion A/S : Interim report Q2 2026 (Presentation)
20/08 Evaxion A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
20/08 European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
20/08 Evaxion A/S : Interim report Q2 2026 (Release)
20/08 Evaxion announces business update and second quarter 2026 financial results
19/08 European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
18/08 European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading
17/08 Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
Aucun résultat pour cette recherche